Structure-guided combination therapy to potently improve the function of mutant CFTRs.
Structure-guided combination therapy to potently improve the function of mutant CFTRs.
复制标题
DOI:
10.1038/s41591-018-0200-x
复制
发表时间:
2018-11
期刊:
影响因子:
82.9
通讯作者:
Lukacs GL
中科院分区:
文献类型:
--
作者:
Veit G;Xu H;Dreano E;Avramescu RG;Bagdany M;Beitel LK;Roldan A;Hancock MA;Lay C;Li W;Morin K;Gao S;Mak PA;Ainscow E;Orth AP;McNamara P;Edelman A;Frenkiel S;Matouk E;Sermet-Gaudelus I;Barnes WG;Lukacs GL
Available drugs are unable to effectively rescue the folding defects in vitro and ameliorate the clinical-phenotype of cystic fibrosis (CF), caused by deletion of F508 (ΔF508 or F508del) and some point mutations in the CF transmembrane conductance regulator (CFTR), a plasma membrane (PM) anion channel. To overcome the corrector efficacy ceiling, here we show that compounds targeting distinct structural defects of CFTR can synergistically rescue mutants expression and function at the PM. High throughput cell-based screens and mechanistic analysis identified three small-molecule series that target defects at the nucleotide binding domain (NBD1), NBD2 and their membrane spanning domains (MSDs) interfaces. While individually these compounds marginally improve ΔF508-CFTR folding efficiency, function, and stability, their combinations lead to ~50–100% of wild type-level correction in immortalized and primary human airway epithelia, and in mouse nasal epithelia. Likewise, corrector combinations were effective for rare missense mutations in various CFTR domains, probably acting via structural allostery, suggesting a mechanistic framework for their broad application.
登录
查看更多内容
影响因子:
16.6
作者:
Bagdany M;Veit G;Fukuda R;Avramescu RG;Okiyoneda T;Baaklini I;Singh J;Sovak G;Xu H;Apaja PM;Sattin S;Beitel LK;Roldan A;Colombo G;Balch W;Young JC;Lukacs GL
通讯作者:
Lukacs GL
影响因子:
5.6
作者:
Cui, Liying;Aleksandrov, Luba;Riordan, John R.
通讯作者:
Riordan, John R.
影响因子:
3.3
作者:
Apaja PM;Foo B;Okiyoneda T;Valinsky WC;Barriere H;Atanasiu R;Ficker E;Lukacs GL;Shrier A
通讯作者:
Shrier A
影响因子:
3.5
作者:
Aleksandrov, AA;Riordan, JR
通讯作者:
Riordan, JR
影响因子:
14.8
作者:
Calamini, Barbara;Silva, Maria Catarina;Madoux, Franck;Hutt, Darren M.;Khanna, Shilpi;Chalfant, Monica A.;Saldanha, S. Adrian;Hodder, Peter;Tait, Bradley D.;Garza, Dan;Balch, William E.;Morimoto, Richard I.
通讯作者:
Morimoto, Richard I.